Yan Lin, Huo Pei, Doherty George, Toth Lesile, Hale Jeffrey J, Mills Sander G, Hajdu Richard, Keohane Carol A, Rosenbach Mark J, Milligan James A, Shei Gan-Ju, Chrebet Gary, Bergstrom James, Card Deborah, Quackenbush Elizabeth, Wickham Alexandra, Mandala Suzanne M
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA.
Bioorg Med Chem Lett. 2006 Jul 15;16(14):3679-83. doi: 10.1016/j.bmcl.2006.04.084. Epub 2006 May 11.
A series of 3-arylpropionic acids were synthesized as S1P1 receptor agonists. Structure-activity relationship studies on the pendant phenyl ring revealed several structural features offering selectivity of S1P1 binding against S1P2-5. These highly selective S1P1 agonists induced peripheral blood lymphocyte lowering in mice and one of them was found to be efficacious in a rat skin transplantation model, supporting that S1P1 agonism is primarily responsible for the immunosuppressive efficacy observed in preclinical animal models.
合成了一系列3-芳基丙酸作为S1P1受体激动剂。对侧链苯环的构效关系研究揭示了几个结构特征,这些特征提供了S1P1与S1P2 - 5结合的选择性。这些高选择性的S1P1激动剂可诱导小鼠外周血淋巴细胞减少,其中一种在大鼠皮肤移植模型中被发现有效,这支持了S1P1激动作用是临床前动物模型中观察到的免疫抑制功效的主要原因。